Back to Search Start Over

Marlboro Maker's Radical Health Foray Upends Role of Big Tobacco.

Authors :
Gretler, Corinne
Source :
Bloomberg.com; 7/21/2021, p1-4, 4p
Publication Year :
2021

Abstract

In one of its boldest and most controversial moves yet, the company said this month that it would buy U.K. asthma drug maker Vectura Group Plc, a deal that would add fresh expertise in devices, inhalation, regulation and clinical manufacturing. Keywords: 3400398Z; 6949817ZLN; BATS@LN; CG; IMB@LN; PM; VEC@LN; ALLTOP; BUSINESS; CONS; CONSD; CONSS; COS; DRG; EUROPE; GEN; GOV; HEA; INDUSTRIAL; INDUSTRIES; LEI; MAC; NORTHAM; POL; RET; TOP; UK; US; WORLD; WWTOP; WWTOPAM EN 3400398Z 6949817ZLN BATS@LN CG IMB@LN PM VEC@LN ALLTOP BUSINESS CONS CONSD CONSS COS DRG EUROPE GEN GOV HEA INDUSTRIAL INDUSTRIES LEI MAC NORTHAM POL RET TOP UK US WORLD WWTOP WWTOPAM Philip Morris's purchase of an inhaler maker has proven controversial QWL92JDWX2QB (Bloomberg) -- When Moira Gilchrist was first approached by Philip Morris International Inc., she wondered what a tobacco company wanted from a scientist who had previously worked on clinical trials for anti-cancer drugs. [Extracted from the article]

Details

Language :
English
Database :
Complementary Index
Journal :
Bloomberg.com
Publication Type :
Periodical
Accession number :
151600878